# Hester Biosciences Q2 Net Profit Rises 44% to ₹206.31 Crore on 38% Revenue Growth

> Hester Biosciences posted a 44% rise in Q2 net profit to ₹206.31 crore and approved a $1 million loan to its Tanzania subsidiary, Hester Africa.

- Published: 2026-11-05T06:31:36+00:00
- Section: Earnings & Results
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-05/hester-biosciences-q2-profit-rise
- Source: [ScanX](https://scanx.trade/stock-market-news/companies/hester-biosciences-q2-results-net-profit-up-41-yoy-20-4-crore/55403497)

## Key takeaways

- Hester Biosciences reported consolidated net profit of ₹206.31 crore for Q2FY27, up 44% year-on-year.
- Consolidated revenue rose 38% to ₹979.12 crore, with Animal Healthcare revenue up 55% to ₹356.48 crore.
- The board approved a $1 million unsecured loan to Hester Biosciences Africa Limited in Tanzania.
- A Gates Foundation loan amendment cut Hester Africa's outstanding principal from $12 million to $5 million and produced a ₹857.68 million exceptional gain in H1FY27.

[Hester Biosciences](https://akta.pro/company-profiles/0005i4q/hester-biosciences) reported consolidated net profit of ₹206.31 crore for the second quarter of FY27, up 44% from ₹143.31 crore a year earlier, on revenue of ₹979.12 crore. [ScanX](https://scanx.trade/stock-market-news/companies/hester-biosciences-q2-results-net-profit-up-41-yoy-20-4-crore/55403497) said the board also approved a $1 million unsecured loan to the company's wholly owned subsidiary in Tanzania.

## Hester Biosciences' Revenue and Margin Gains

Revenue rose 38% from ₹709.69 crore in the same quarter last year. Consolidated EBITDA grew 55% to ₹365.16 crore from ₹235.97 crore, and the EBITDA margin widened to 37% from 33%.

Standalone net profit rose 131% to ₹166.60 crore, and standalone revenue grew 28% to ₹829.28 crore. Poultry Healthcare revenue increased 29% to ₹622.64 crore, while Animal Healthcare revenue rose 55% to ₹356.48 crore, which ScanX attributed mainly to higher tender execution during the quarter.

The board approved the $1 million unsecured loan to [Hester Biosciences](https://akta.pro/company-profiles/004kiij/hester-biosciences-limited) Africa Limited for business and general corporate purposes, including working capital. During the six months ended September 30, 2026, Hester Africa amended its loan agreement with the Gates Foundation, reducing the outstanding principal from $12 million to $5 million, waiving all accrued interest and making the revised loan interest-free. The change produced a gain of ₹857.68 million, recorded as an exceptional item in the H1FY27 consolidated results.

## Hester Biosciences' Facility and Vaccine Pipeline

According to akta.pro [company records](https://akta.pro/company-data), Hester Biosciences capitalized its fill-finish facility to double drug product capacity and also capitalized its BSL-3 facilities. The same records show the company advanced a combination vaccine for small ruminants through regulatory review under the GALVmed-led VITAL project, with four additional combination vaccines also in regulatory review. Hester Biosciences describes itself as an animal biologicals manufacturer producing vaccines and healthcare products for poultry, livestock and pets across more than 35 countries, with plants in India, Nepal and Tanzania.

## Hester Biosciences' Recent Deal Activity

In October 2026, Hester Biosciences approved an investment of up to ₹10.50 million in Slyce Agri World LLP for renewable energy, representing a 26% stake in fixed capital, ScanX reported. In July 2026, the company completed the sale of its full 11% equity stake in Texas Lifesciences Private Limited for INR 23 million, transferring 543,248 shares to existing shareholders, according to ScanX. In May 2026, Business Standard reported that Hester Biosciences' consolidated net profit rose 1138.76% to Rs 15.98 crore for the quarter ended March 2026.

## Hester Biosciences' Q2 Results Timing

Hester Biosciences closed its trading window from October 1, 2026, ahead of announcing its Q2FY27 and H1FY27 results, ScanX reported. The window remains open for 48 hours after the results are public.

## Companies in this story

- [Hester Biosciences company profile](https://akta.pro/company-profiles/0005i4q/hester-biosciences) · website: http://www.hesterbiosciences.co.in
- [Hester Biosciences Limited company profile](https://akta.pro/company-profiles/004kiij/hester-biosciences-limited) · website: https://hester.in

---
News for Agent · https://newsforagent.com/llms.txt